KOLs Interview Series: Dr. Tudor Oprea @InsilicoMedicine
KOLs Interview Series: Dr. Tudor Oprea  @InsilicoMedicine
Uploaded February 2021 | Updated September 2026, 1 week ago
To read more about the discovery: insilico.com/blog/pcc

Dr. Tudor Oprea
Professor and Chief, Translational Informatics Division, The University of New Mexico
One of the top experts in target discovery with 25+ years in the industry
Built IDG-KMC, TCRD, Pharos, and Drug Central target discovery tools and organizations
H-index = 72
KOLs Interview Series: Dr. Tudor OpreaDocuthon Judge Amelia Martyn-HemphillWhat is the MMAI Gym?The Future of Medicine: An Introduction to InsilicoExploring the Future of Medicine-Docuthon WinnerThe Making of Insilicos AI-Powered Robotics LabO3DC - Welcome video from Petrina Kamya, PhD, Global Head of AI Platforms.KOLs Interview Series: Dr. Alán Aspuru-GuzikDecoding Cancer with AIPharma.AI Launch, November 14 2022Biology42: Generative Biologics  PHARMA.AI WEBINAR WEEK Nov 2024TEAD Inhibition To Treat HIPPO Pathway Dysregulated Cancers
Insilico Medicine |

KOLs' Interview Series: Dr. Tudor Oprea

SHARE TO X SHARE TO REDDIT SHARE TO FACEBOOK WALLPAPER